Skip to main content
CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.33
-0.09 (-1.07%)
At close: Dec 24, 2024, 1:00 PM
8.15
-0.18 (-2.16%)
After-hours: Dec 24, 2024, 3:45 PM EST

CorMedix Revenue

CorMedix had revenue of $11.46M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $12.26M, up 41,184.20% year-over-year.

Revenue (ttm)
$12.26M
Revenue Growth
+41,184.20%
P/S Ratio
39.30
Revenue / Employee
$147,738
Employees
83
Market Cap
505.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019283.27K-146.53K-34.09%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.17B
Ginkgo Bioworks Holdings 217.95M
Talkspace 181.29M
Sangamo Therapeutics 52.29M
EyePoint Pharmaceuticals 45.71M
Phathom Pharmaceuticals 26.27M
Verve Therapeutics 24.40M
Revenue Rankings

CRMD News

More News